Hughes Steven George bought RNA
August 22, 2025 · Form 4 insider transaction
Hughes Steven George bought 2,208 shares of Atrium Therapeutics, Inc. at $10.16 per share, a transaction worth $22.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,208
Price
$10.16
Total value
$22.4K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 22, 2025
Filing dateAugust 22, 2025
Shares owned after41,075
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.